ArticleAging2024

CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers.

Juntao Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.